°è¨é§°èé¨èéè
¨727è8284±§èJCS 20202020¤è¤§APSC 2020è·é¤§éèShingo Yanagiya訤鷧éèéééè·éé訧éèéééééé
é褰¤§
°èè2015¨éè°11.3§§¤èè1.5è¨éè30-45·§24%§20%
許èééééèèè餧 60¤·èè60éèé±è褨¤¨¤¨éè°§°è°2025éèè°°15-20è15[1]
2019éèé°è2018±°è§20152012¨18éè25.2%è§ééèèè°ééèè°China Hypertension SurveyCHS)201210è201512騱¤éé·¨31èè°éé¨26218451 755±°èèè°
¤18éè27.9%,23.2%éèé28.8%vs.26.9%)·§éèé§28.6%vs.27.2%24.5%vs.21.9%)
éééèééèè褷±°éè±35.9%34.5%29.1%±°éè15.6%¤¤éé°BMIéèéé
1: éèé[2]
éè¨éè訧èè20151000éèè490è§èè350é
¨°±èè1000éèèè°è¨§Yanagiyaèéè§èé¤ééé¤é±èè°èéé·
J-HOPE §
Yanagiyaé¨èèJ-HOPE §è°¨è·éèé2012±¨12·4,314·é¤è·3,153·§1,161§
°è·±500500~790800~9901000§è°è·¤éè±é
±·§é±·§éèè§é·§¨500~790800~990·§éèééé50è騨800~990§°è°èp>0.05
èè°è§éèé§éè·°è°é¨èèéèé°BMIkg/m 2觱¨é¤·§§éèééèé
訧èéèèééèééèé
Yanagiyaè§éé¨éè°§°é·§è¨èé·§éè¤éééèèè褧èééè±é
é·éè¨
Yanagiyaèé¤éè·°¤éèèé¨é·§éè·¤§°èééé
éèèéè±é°°éé10g/dèWHO¨è2 g/dèè¤é¤èéè·§éèèèééèè騤éé
éè§éé
2020·ééèè°éè§éééèè[3]
2·ééèè°
1.èèéèèéé¤è·èè¤èèéèèèéè°é¤·è°·±ééééééèèéèè¨è駱:è°·±250400gé;èè300500géèèèè±èèèéè;°100200g;éè;é200g;è50g;è±è100g;éè1;é±è100g;éé 100géè±è±25gé5gé¨è15gé¤é±
2.ééè¨éè¨éè¨é:éè§èè°¤§
3.éééèéèè°èéè±é§èéééèéè±é§70%90%éééé¨10g
4.èèéè§éééèèèèè§è餧èèèè°¤éè褰èè±éè±èè¤èèéè§èéèéèé豧è±é
5.èèèèèè°è§èè:90140mmHg;è6090mmHg°¨é3é
6.§éé觰éèè20%éèééé23èèèèèè°èèè¤
7.èéé¤éééè¤èèè°è褧é±éèè·
è
1. Williams, B., et al., 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J, 2018. 39(33): p. 3021-3104.
2. Kearney, P.M., et al., Global burden of hypertension: analysis of worldwide data. Lancet, 2005. 365(9455): p. 217-23.
3. ·ééèè°. ·, 2020(02): p. 113-134.
·
è·